Risk of mortality in patients with cancer who experience febrile neutropenia.

Publication Type:

Journal Article

Source:

Cancer, Volume 116, Issue 23, p.5555-63 (2010)

Keywords:

Antineoplastic Combined Chemotherapy Protocols, Bone Marrow, Female, Fever, Hospitalization, Humans, Male, Middle Aged, Neoplasms, NEUTROPENIA, Retrospective Studies, RISK, Time Factors

Abstract:

Febrile neutropenia (FN) is a serious and potentially life-threatening condition that may develop in patients with cancer who receive myelosuppressive chemotherapy. The risk of mortality from FN is not well characterized in current clinical practice.